Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC - Güttlein, Leandro N.; Benedetti, Lorena G.; Fresno, Cristóbal; Spallanzani, Raúl G.; Mansilla, Sabrina F.; Rotondaro, Cecilia; Raffo Iraolagoitia, Ximena L.; Salvatierra, Edgardo; Bravo, Alicia I.; Fernández, Elmer A.; Gottifredi, Vanesa; Zwirner, Norberto W.; et al. (Molecular cancer research, 2017)
Keywords: Animal models; Animals; Breast cancer; Breast Neoplasms - enzymology; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - pathology; Cancer; Cell cycle; Cell Growth Processes - physiology; Cell Line, Tumor; Colonization; Cyclooxygenase-2; ErbB-2 protein; Female; Gene expression; Glycoproteins; Humans; Implantation; Lungs; Mammary Neoplasms, Experimental - enzymology; Mammary Neoplasms, Experimental - genetics; Mammary Neoplasms, Experimental - metabolism; Mammary Neoplasms, Experimental - pathology; MCF-7 Cells; Metastases; Metastasis; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Osteonectin; Osteonectin - genetics; Osteonectin - metabolism; Prognosis; Receptor, ErbB-2 - genetics; Receptor, ErbB-2 - metabolism; Signatures; Stroma; Suppressor cells; Treatment Outcome